The needle that makes brain surgery safer


Monday, 23 January, 2017

The needle that makes brain surgery safer

Researchers at the University of Adelaide have developed a brain biopsy needle with a tiny imaging probe inside, enabling surgeons to ‘see’ and avoid at-risk blood vessels as they insert the needle into patients’ brains.

Professor Robert McLaughlin, chair of Biophotonics at the university’s Centre for Nanoscale BioPhotonics, explained that surgeons currently rely on scans taken prior to surgery to avoid hitting blood vessels — a method which is unfortunately not as accurate as surgeons would like.

“There are about 256,000 cases of brain cancer a year and about 2.3% of the time you can make a significant impact that could end in a stroke or death,” he noted.

The smart needle, on the other hand, works “sort of like an ultrasound but with light instead”, said Professor McLaughlin. “It contains a tiny fibre-optic camera, the size of a human hair, shining infrared light to see the vessels before the needle can damage them.

“It also has smart software that takes the picture, analyses it and it can determine if what it is seeing is a blood vessel or tissue,” he said.

Professor McLaughlin and his team are already in discussions with medical device manufacturers with a view to manufacture the smart needles here in Australia. According to Professor McLaughlin, manufacturing could feasibly begin within five years.

“It’s an ideal technology to commercialise in Australia,” said Professor McLaughlin. “We have the engineering expertise and world-class hospitals here, and enthusiasm from the surgeons.”

The smart needle has been used as part of a pilot trial in neurosurgery patients at Sir Charles Gairdner Hospital, Western Australia, for the past six months. It will be ready for formal clinical trials in 2018.

Related News

Scientists find new driver of ovarian cancer spread

A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...

Hormone therapy shifts body proteins to match gender identity

Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

Targeting 'molecular bodyguards' weakens prostate cancer cells

Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd